We are excited to announce the addition of two new partners to the OptiVisT consortium: MindAffect and Johnson & Johnson Vision. These organizations will primarily contribute by offering valuable secondment opportunities to our Early Stage Researchers (ESRs). Their expertise and support will greatly enhance our mission to advance research and innovation within the consortium. Welcome aboard!
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 955590
STARTING DATE: 01/03/2021
COMPLETION DATE: 28/02/2025